Response Rate of Cisplatin Plus Docetaxel as Primary Treatment in Locally Advanced Head and Neck Carcinoma (Squamous Cell Types)

OBJECTIVE: To evaluate the response rate of Cisplatin plus Docetaxel in the treatment of locally advanced head and neck squamous cell carcinomas (HNSCC) at a tertiary care hospital in Karachi, Pakistan. MATERIALS AND METHODS: It was a longitudinal study, conducted at the Department of Medical Oncolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Nouman, Maryum, Haider, Ghulam, Bukhari, Neelma, Yousuf, Aveen, Nouman, Rabeea, Shaikh, Mehwish Roshan, Hussain, Shahid, Pavan, Bhunisha, Rahool, Raja, Memon, Paras, Zahoor, Saima, Mehar, Khalil, Sami, Abdus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437326/
https://www.ncbi.nlm.nih.gov/pubmed/32212813
http://dx.doi.org/10.31557/APJCP.2020.21.3.825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437326/
https://www.ncbi.nlm.nih.gov/pubmed/32212813
http://dx.doi.org/10.31557/APJCP.2020.21.3.825

Ejemplares similares